These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19811279)

  • 1. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
    Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
    Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis.
    Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I
    Lupus; 2006; 15(2):80-6. PubMed ID: 16539278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Hurley BL; Lopez LR
    Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
    Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
    Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
    Kobayashi K; Lopez LR; Matsuura E
    Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus.
    Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P
    Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis in autoimmune diseases.
    Matsuura E; Kobayashi K; Lopez LR
    Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
    Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
    Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
    George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
    Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
    Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis.
    Lopez LR; Kobayashi K; Matsunami Y; Matsuura E
    Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome.
    Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR
    Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?].
    Kraml P
    Vnitr Lek; 2016; 62(11 Suppl 4):S48-51. PubMed ID: 27921425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
    Rauch J; Salem D; Subang R; Kuwana M; Levine JS
    Front Immunol; 2018; 9():2836. PubMed ID: 30619248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
    Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
    Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.